NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
NASDAQ:NLSP
Price:
0.1419 USD
2.38%
Market Closed
Updated:
May 9, 2024
NLS Pharmaceutics AG
Cash from Operating Activities
|
NLS Pharmaceutics AG
Cash from Operating Activities Peer Comparison
Comparables:
NOVN
ROG
S
SDZ
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Operating Activities
-$13.9m
|
CAGR 3-Years
-318%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Novartis AG
SIX:NOVN
|
Cash from Operating Activities
$13.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Roche Holding AG
SIX:ROG
|
Cash from Operating Activities
CHf16.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Operating Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is NLS Pharmaceutics AG's Cash from Operating Activities?
Cash from Operating Activities
-13.9m
USD
-13.9m
USD
Based on the financial report for Dec 31, 2022, NLS Pharmaceutics AG's Cash from Operating Activities amounts to -13.9m USD.
What is NLS Pharmaceutics AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-21%
-21%
Over the last year, the Cash from Operating Activities growth was 7%. The average annual Cash from Operating Activities growth rates for NLS Pharmaceutics AG have been -318% over the past three years , -21% over the past five years .
You don't have any saved screeners yet
